- Home
- WFG vs GKOS Comparison
WFG vs GKOS Comparison
Compare WFG & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFG
- GKOS
- Stock Information
- Founded
- WFG 1955
- GKOS 1998
- Country
- WFG Canada
- GKOS United States
- Employees
- WFG N/A
- GKOS N/A
- Industry
- WFG
- GKOS Medical/Dental Instruments
- Sector
- WFG
- GKOS Health Care
- Exchange
- WFG Nasdaq
- GKOS Nasdaq
- Market Cap
- WFG 7.8B
- GKOS 7.4B
- IPO Year
- WFG N/A
- GKOS 2015
- Fundamental
- Price
- WFG $91.87
- GKOS $138.39
- Analyst Decision
- WFG Buy
- GKOS Strong Buy
- Analyst Count
- WFG 4
- GKOS 12
- Target Price
- WFG $106.25
- GKOS $135.08
- AVG Volume (30 Days)
- WFG 161.0K
- GKOS 600.5K
- Earning Date
- WFG 10-23-2024
- GKOS 11-04-2024
- Dividend Yield
- WFG 1.39%
- GKOS N/A
- EPS Growth
- WFG N/A
- GKOS N/A
- EPS
- WFG N/A
- GKOS N/A
- Revenue
- WFG $6,283,000,000.00
- GKOS $360,347,000.00
- Revenue This Year
- WFG N/A
- GKOS $22.68
- Revenue Next Year
- WFG $6.67
- GKOS $24.98
- P/E Ratio
- WFG N/A
- GKOS N/A
- Revenue Growth
- WFG N/A
- GKOS 18.70
- 52 Week Low
- WFG $72.35
- GKOS $59.22
- 52 Week High
- WFG $102.40
- GKOS $145.84
- Technical
- Relative Strength Index (RSI)
- WFG 44.16
- GKOS 55.15
- Support Level
- WFG $90.73
- GKOS $124.60
- Resistance Level
- WFG $93.52
- GKOS $145.84
- Average True Range (ATR)
- WFG 2.63
- GKOS 5.15
- MACD
- WFG -0.15
- GKOS 0.30
- Stochastic Oscillator
- WFG 36.36
- GKOS 64.92
About WFG West Fraser Timber Co. Ltd Common stock
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is now one of the largest oriented strand board, or OSB, producers in the world.
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.